Clinical Trials Directory

Trials / Terminated

TerminatedNCT02375048

Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI

Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation (WBI) Versus Accelerated Partial Breast Irradiation (APBI)

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
179 (actual)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
Female
Age
55 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Selected patients with early stage breast cancer undergone conservative surgery were randomized in two arms: Hypofractionated Whole Breast Irradiation versus Accelerated Partial Breast Irradiation.

Detailed description

Patients treated with Hypofractionated Whole Breast Irradiation (WBI) received SIB irradiation of the whole breast and surgical bed at two different dose levels. Dose prescription was 40.5 Gy to PTVWB and 48.0 Gy to PTVboost in 15 fractions over 3 weeks, with simultaneous integrated boost delivering 2.7 and 3.2Gy/fraction for each PTV respectively. Daily image guided radiotherapy (IGRT) were generated before each treatment session in each patient to verify the set-up. Accelerated Partial Breast Irradiation (APBI) using external intensity -modulated radiotherapy (VMAT RA) was delivered at a dose of 30 Gy in five 6-Gy/day fractions over 10 days (every other day) with IGRT at each treatment.

Conditions

Interventions

TypeNameDescription
RADIATIONHypofractionated WBIDose prescription was 40.5 Gy to PTVWB and 48.0 Gy to PTVboost in 15 fractions over 3 weeks, with simultaneous integrated boost delivering 2.7 and 3.2Gy/fraction for each PTV respectively. Daily image guided radiotherapy (IGRT) were generated before each treatment session in each patient to verify the set-up.
RADIATIONAccelerated Partial Breast IrradiationAPBI was delivered at a dose of 30 Gy in five 6-Gy/day fractions over 10 days (every other day) with IGRT at each treatment.

Timeline

Start date
2015-01-19
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2015-03-02
Last updated
2018-10-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02375048. Inclusion in this directory is not an endorsement.